Baird’s Pfizer PFE Stock Holding History

Baird’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$39.7M	Sell	1,201,484 -28,033	-2%	-$891K	0.41%	69
2014 Q4	$36.3M	Buy	1,229,517 +252,451	+26%	+$7.24M	0.39%	75
2014 Q3	$27.4M	Buy	977,066 +14,152	+1%	+$397K	0.38%	91
2014 Q2	$27.1M	Buy	962,914 +24,967	+3%	+$712K	0.38%	86
2014 Q1	$28.6M	Buy	937,947 +15,300	+2%	+$456K	0.41%	74
2013 Q4	$26.8M	Sell	922,647 -51,273	-5%	-$1.49M	0.46%	38
2013 Q3	$26.5M	Buy	973,920 +74,354	+8%	+$2.02M	0.49%	37
2013 Q2	$23.9M	Buy	+899,566	New	+$24.9M	0.48%	42

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Baird's PFE Position: Q1 2015 in Review

Baird reduced its Pfizer (PFE) stake by 2.3% in Q1 2015, selling an estimated $891K and leaving 1,201,484 shares worth $39.7M. The position accounts for 0.41% of the portfolio, ranked #69.

Baird first reported a position in PFE in Q2 2013 and has held it in 8 quarters since. 1,875 funds tracked by Wall St. Rank hold PFE as of Q1 2015.

Baird held 1,201,484 shares of Pfizer worth $39.7M as of Q1 2015.
Baird sold 28,033 Pfizer shares in Q1 2015, an estimated $891K.
Pfizer made up 0.41% of Baird's portfolio in Q1 2015, its #69 holding.
Baird first reported a position in Pfizer in Q2 2013 and has held it in 8 quarters since.
1,875 funds tracked by Wall St. Rank held Pfizer as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.